Cargando…

5. Isolated head drop: first symptom of anti-synthetase syndrome

INTRODUCTION: Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. CASE DESCRIPTION: A 72-year-old man with a background of extractable nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Lucy, Soliotis, Fotini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761427/
http://dx.doi.org/10.1093/rap/rkz030.004
_version_ 1783454030713847808
author Parker, Lucy
Soliotis, Fotini
author_facet Parker, Lucy
Soliotis, Fotini
author_sort Parker, Lucy
collection PubMed
description INTRODUCTION: Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. CASE DESCRIPTION: A 72-year-old man with a background of extractable nuclear antigen (ENA) negative mixed connective tissue disease, trigeminal neuralgia, interstitial nephritis and ischaemic heart disease presented with an isolated head drop. On further prompting, he confirmed mild shortness of breath on exertion. He had sclerodactyly but no features of mechanic’s hands. Serum creatinine kinase was 1398 IU/L. Electromyography was myelopathic. Muscle biopsy taken from the neck was inconclusive. He had a strongly positive anti-nuclear antibody (ANA) test, and borderline myositis ENA panel result with borderline positive anti-EJ antibody. The myositis panel result prompted further investigation for underlying interstitial lung disease. Pulmonary function testing revealed a restrictive picture, with KCO of 82%. High resolution computed tomography showed areas of fine interstitial fibrotic change in all lobes. He was treated with a reducing course of oral prednisolone and 15mg weekly oral methotrexate with an excellent clinical response, with resolution of the head drop and normalisation of serum CK value. Repeat pulmonary function testing remains stable after 5 months. DISCUSSION: This is an unusual presentation of presumed anti-synthetase syndrome. As methotrexate had already been prescribed before the underlying lung pathology was identified with resulting excellent clinical response and stable respiratory symptoms, a multi-disciplinary decision was made to continue with this choice of disease modifying agent. The decision to use methotrexate in the presence of interstitial fibrosis is always difficult, and requires close liaison between rheumatology and respiratory colleagues. KEY LEARNING POINTS: Positive anti-synthetase antibodies should prompt further investigation for underlying interstitial lung disease. Head drop can be a first symptom of autoimmune myositis and warrants further investigation. CONFLICTS OF INTEREST: The authors have declared no conflicts of interest.
format Online
Article
Text
id pubmed-6761427
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67614272019-10-02 5. Isolated head drop: first symptom of anti-synthetase syndrome Parker, Lucy Soliotis, Fotini Rheumatol Adv Pract Poster Presentations INTRODUCTION: Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. CASE DESCRIPTION: A 72-year-old man with a background of extractable nuclear antigen (ENA) negative mixed connective tissue disease, trigeminal neuralgia, interstitial nephritis and ischaemic heart disease presented with an isolated head drop. On further prompting, he confirmed mild shortness of breath on exertion. He had sclerodactyly but no features of mechanic’s hands. Serum creatinine kinase was 1398 IU/L. Electromyography was myelopathic. Muscle biopsy taken from the neck was inconclusive. He had a strongly positive anti-nuclear antibody (ANA) test, and borderline myositis ENA panel result with borderline positive anti-EJ antibody. The myositis panel result prompted further investigation for underlying interstitial lung disease. Pulmonary function testing revealed a restrictive picture, with KCO of 82%. High resolution computed tomography showed areas of fine interstitial fibrotic change in all lobes. He was treated with a reducing course of oral prednisolone and 15mg weekly oral methotrexate with an excellent clinical response, with resolution of the head drop and normalisation of serum CK value. Repeat pulmonary function testing remains stable after 5 months. DISCUSSION: This is an unusual presentation of presumed anti-synthetase syndrome. As methotrexate had already been prescribed before the underlying lung pathology was identified with resulting excellent clinical response and stable respiratory symptoms, a multi-disciplinary decision was made to continue with this choice of disease modifying agent. The decision to use methotrexate in the presence of interstitial fibrosis is always difficult, and requires close liaison between rheumatology and respiratory colleagues. KEY LEARNING POINTS: Positive anti-synthetase antibodies should prompt further investigation for underlying interstitial lung disease. Head drop can be a first symptom of autoimmune myositis and warrants further investigation. CONFLICTS OF INTEREST: The authors have declared no conflicts of interest. Oxford University Press 2019-09-26 /pmc/articles/PMC6761427/ http://dx.doi.org/10.1093/rap/rkz030.004 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Presentations
Parker, Lucy
Soliotis, Fotini
5. Isolated head drop: first symptom of anti-synthetase syndrome
title 5. Isolated head drop: first symptom of anti-synthetase syndrome
title_full 5. Isolated head drop: first symptom of anti-synthetase syndrome
title_fullStr 5. Isolated head drop: first symptom of anti-synthetase syndrome
title_full_unstemmed 5. Isolated head drop: first symptom of anti-synthetase syndrome
title_short 5. Isolated head drop: first symptom of anti-synthetase syndrome
title_sort 5. isolated head drop: first symptom of anti-synthetase syndrome
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761427/
http://dx.doi.org/10.1093/rap/rkz030.004
work_keys_str_mv AT parkerlucy 5isolatedheaddropfirstsymptomofantisynthetasesyndrome
AT soliotisfotini 5isolatedheaddropfirstsymptomofantisynthetasesyndrome